Tomotaka Suzuki

8PUBLICATIONS
24CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 20, 2025
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.

Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji

|May 07, 2025
Prevalence of CCR7-Positive CD8 T Cells as a Prognostic Factor in B-Cell Maturation Antigen -Targeted Chimeric Antigen Receptor T Cell Therapy.

Yoshiaki Marumo, Masaki Ri, Toru Ebina

|Apr 23, 2025
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma.

Tomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga

|Jan 12, 2024
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.

Kentaro Hirade, Shigeru Kusumoto, Hiroya Hashimoto

|Apr 27, 2023
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.

Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki

|Jul 13, 2022
Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan.

Tomotaka Suzuki, Dai Maruyama, Shinsuke Iida

Pageof 2

Frequent Collaborators

4 joint publications

Masaki Ri

3 joint publications

Shigeru Kusumoto

2 joint publications

Dai Maruyama

2 joint publications

Hiroya Hashimoto